#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Trigeminal neuralgia Ventricular fibrillation Castleman's disease Liposarcoma recurrent Immunodeficiency congenital X-linked lymphoproliferative syndrome Peripheral primitive neuroectodermal tumour of soft tissue Cervix carcinoma Narcolepsy Becker's muscular dystrophy Mucous membrane pemphigoid Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency SAPHO syndrome Neurotrophic keratopathy Alpha-1 antitrypsin deficiency More trials…

    Learn about Rare Diseases

    Retinoblastoma Lymphangioma Congenital nephrogenic diabetes insipidus – Life with Disease Ornithine transcarbamoylase deficiency – Trials in Disease X-linked lymphoproliferative syndrome – Basic Information Andersen-Tawil syndrome – Treatment Loeys-Dietz syndrome – Life with Disease Isodicentric chromosome 15 syndrome – Treatment Turner’s syndrome Langerhans’ cell histiocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Crovalimab Aclidinium Bromide Doxylamine Hydrogen Succinate OBI-821 NORGESTIMATE Nanatinostat Octreotide Hydrochloride Alternaria Alternata (402) Alirocumab INSULIN DEGLUDEC Clofarabine RNK001 VERT-002 Ethinylestradiol Botaretigene Sparoparvovec Heparin Ict01 Naltrexone Hydrochloride Tumour Detection Elotuzumab More therapies…

    Learn about Your Condition

    Oedema peripheral Notalgia paraesthetica Apathy Toxic epidermal necrolysis Sarcoma metastatic Procedural anxiety Hernia repair Fatty acid oxidation disorder Fontan procedure Malignant oligodendroglioma Leber's congenital amaurosis Herpes virus infection Castleman's disease Friedreich's ataxia Inner ear disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diagnosis

  • Study of Zirconium-89 Girentuximab as a Diagnostic Tool for Patients with Von-Hippel Lindau Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Von Hippel-Lindau disease
    Investigated Drugs:
    • ZIRCONIUM (89ZR) GIRENTUXIMAB
    Italy

  • Safety and imaging quality study of perflutren contrast agent (HarMono-T) during kidney ultrasound in healthy volunteers

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Perflutren
    Germany

  • Study of Ferumoxtran-10 Enhanced MRI for Detecting Lymph Node Metastases in Patients with Esophageal Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • FERUMOXTRAN-10
    The Netherlands

  • Comparing Lung Perfusion PET/CT-Guided Versus Standard Planning for Stereotactic Body Radiotherapy in Patients with Primary or Secondary Lung Tumors

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Human Albumin As Macroaggregates
    • Gallium (68Ga)
    France

  • Study of serotonin system changes in early Parkinson’s disease using [11C]DASB and [11C]SB207145 PET imaging in people with SNCA gene mutations

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • (1-(11C)METHYLPIPERIDIN-4-YL)METHYL 5-AMINO-6-CHLORO-1,4-BENZODIOXINE-8-CARBOXYLATE
    • 3-AMINO-4-[2-[[METHYL((111C)METHYL)AMINO]METHYL]PHENYL]SULFANYLBENZONITRILE
    France

  • Safety and Effectiveness of Intravenous Sonazoid for Contrast-Enhanced Liver Ultrasound in Children with Focal Liver Lesions

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Perflubutane
    Germany Italy
Previous Page
1 … 11 12 13 14 15 … 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!